Hims & Hers Health adds compounded GLP-1 injections to weight loss program

Digital pharmacy startup Hims & Hers Health is introducing access to compounded GLP-1 weight loss injections, the company announced Monday. The GLP-1 market, dominated so far by pharmaceutical giant Novo Nordisk, has faced supply constraints in recent months as the drugs get expanded approval from health regulators and increased health coverage. GLP-1s work by mimicking a hormone produced in the gut to tamp down a person's appetite and regulate their blood sugar. When those medications are in shortage, cert ...